Sponsors (4)
The bill expands short-term access to substitute medicines during shortages and improves transparency and supply flexibility, but it raises safety concerns, may weaken incentives for domestic production, and could shift costs or delay relief in some cases.
Patients with chronic conditions and seniors can access substitute drugs imported temporarily (within 60 days), reducing treatment interruptions during shortages.
Hospitals and health systems gain quicker access to alternative suppliers through expedited review and temporary importation authorities, improving continuity of care in marginal markets.
Patients and health providers may see expanded long-term supply options because imported products must match the active ingredient and manufacturers must commit to seeking ANDA approval.
Patients with chronic conditions and seniors face increased safety risks because imported drugs could later lose foreign approvals and FDA's discretionary denials may not eliminate all unsafe products.
Small U.S. drug manufacturers and hospitals may see reduced incentives for domestic production and weakened long-term supply resilience if temporary imports undercut U.S. producers.
Taxpayers and Medicaid beneficiaries could incur additional costs if multi‑year import authorizations shift oversight, litigation, or recall liabilities onto payers or public programs.
Based on analysis of 2 sections of legislative text.
Introduced July 17, 2025 by Amy Klobuchar · Last progress July 17, 2025
Creates a temporary FDA importation authority to allow certain prescription drugs to be imported for up to three years when there is a shortage or when a market is judged “marginally competitive.” It sets objective criteria for identifying marginally competitive markets, requires an expedited review timeline (authorization no later than 60 days after required information is submitted unless safety concerns justify denial), allows the FDA to refuse imports for safety reasons, and requires reporting on the number of drugs authorized for importation.